WebApr 12, 2024 · The target price remains set at CHF 85. April 13, 2024. In a research note, JP Morgan analyst Richard Vosser has maintained his recommendation on the stock with a Neutral rating. The target price remains set at CHF 85. April 13, 2024 ... NOVARTIS AG : Gets a Neutral rating from JP Morgan. 04/12/2024 05:56am EDT *: *: * In a research note … WebIpsen – JP Morgan 2024 Healthcare Conference . 06 January 2024. Oddo BHF Forum, Lyon (Management) Oddo BHF Forum presentation 2024 . 05 January 2024. ... Ipsen – JP Morgan 2024 presentation . 11 January 2024. J.P. Morgan Healthcare Conference, San Francisco (Management) Ipsen – JP Morgan 2024 presentation .
2024 J.P. Morgan Healthcare Investor Conference Deloitte US
WebApr 12, 2024 · Novartis Neutral. NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Novartis vor Quartalszahlen auf "Neutral" mit einem Kursziel von 85 Franken belassen. Der Pharmakonzern ... Web2 days ago · Presentation at: ARVO Annual Meeting; 2024 April 23-27 Presentation #2816.[3] Pollreisz A, et al. Faster time to retinal fluid control with faricimab versus aflibercept in patients with DME in the ... simple choice coffee
Events & Presentations - JPMorgan Chase
WebNine-month 2024 sales Presentation with appendix European Society for Medical Oncology (ESMO) 2024 Congress Highlights from Roche Roche Pharma Day 2024 - Pipeline overview WebJan 14, 2014 · Presenter SpeechJames Gordon Good morning, everybody. I'm James Gordon, JP Morgan European pharmaceuticals analyst. And this morning, I got the pleasure of introducing the GSK presentation. So you're... 15 April 2024 Web1 day ago · Presentation Operator MessageOperator Good morning, ladies and gentlemen. Welcome to the [ JPMorgan Chase's ] First Quarter 2024 Earnings Call. This call is being recorded. [Operator Instructions] We... April 14, 2024 simple choice north america 5g